Table 2.

Demographic and disease characteristics of MSI-H patients treated with perioperative FLOT in a real-world setting

MSI-H patient	Sex	Age at the time of diagnosis (years)	Primary tumor location	Lauren’s type	Baseline clinical stage	Clinical response
N1	Male	75	GC	NA	III	PR
N2	Female	65	GC	NA	III	PR
N3	Female	72	GC	Intestinal	III	SD
N4	Male	57	GC	Mixed	II	SD
N5	Male	73	GC	Diffuse	I	SD
N6	Male	73	GC	Intestinal	III	SD
N7	Male	69	GEJ	Intestinal	III	PD
N8	Female	73	GC	Diffuse	III	PR
N9	Female	67	GC	NA	II	SD

Abbreviations: GC gastric cancer; GEJ gastro-oesophageal junction; MSI-H microsatellite instability-high; NA not assessed; PD progressive disease; PR partial response; SD stable disease